A Phase 1, Open Label Study To Investigate The Pharmacokinetics Of Multiple Doses Of PF-04531083 Tablets In Healthy Volunteers.
Latest Information Update: 10 Aug 2010
At a glance
- Drugs PF 4531083 (Primary) ; PF 4531083
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 05 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.